13440-76-1

Basic information

• Product Name: Cyclohexanone, 2,2,4,4-tetramethyl-
• CAS NO: 13440-76-1
• Molecular Formula: C10H18O
• Molecular Weight: 154.252
• Mol File: 13440-76-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Cyclohexanone, 2,2,4,4-tetramethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanone, 2,2,4,4-tetramethyl-(13440-76-1)
• EPA Substance Registry System: Cyclohexanone, 2,2,4,4-tetramethyl-(13440-76-1)

Safety Data

• Hazardous Substances Data: 13440-76-1(Hazardous Substances Data)

Upstream product

• 32264-57-6 4,4,6,6-tetramethylcyclohex-2-en-1-one 
• 1073-13-8 4,4-dimethylcyclohexenone 
• 74-88-4 methyl iodide 
• 13395-71-6 2,4,4-trimethyl-2-cyclohexenone 
• 21592-93-8 4,4,6,6-Tetramethyl-cyclohexen-⁽²⁾-ol-⁽¹⁾ 

Downstream Products

• 427898-75-7 2-acetyl-4,4,6,6-tetramethylcyclohex-2-enone 
• 427898-76-8 4,4,6,6-tetramethyl-2-(trifluoroacetyl)cyclohex-2-enone 
• 1207109-99-6 6-hydroxymethylene-2,2,4,4-tetramethylcyclohexanone 
• 1207110-52-8 3,3,5,5-tetramethyl-2-oxocyclohexanecarbonitrile 
• 1207110-53-9 3,3,5,5-tetramethyl-2-oxocyclohex-1-enecarbonitrile 

Relevant articles and documents

Chromene compound

PROBLEM TO BE SOLVED: To provide a chromene compound having little discoloration in a non-irradiation state.SOLUTION: This chromene compound is represented by general formula (1) {in the formula, Ris an alkyl group; Rand Rare each independently a hydrogen atom, an alkyl group or an alkoxy group; Rand Rare each independently a hydrogen atom or the like; Rand Rare each independently a hydroxy group or the like; Rand Rare each independently an aryl group or the like; Z is a divalent group selected from an alkylene group, a cycloalkylene group or an arylene group; a is an integer of 0-2; and b is an integer of 0-4}.

MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF

The present invention features monocyclic cyanoenone compositions and methods for using the same in the treatment of diseases such as cancer, inflammatory diseases and neurodegenerative diseases.